'Dawn of a New Era'
Geron Soars as First ESC Trial Clears FDA Hurdle
By Jennifer Boggs
Monday, January 26, 2009
Embryonic stem cells, which have been hailed as a potential revolutionary development in the field of regenerative medicine since the creation of the first cell line more than 10 years ago and also have generated a hailstorm of controversy in political and religious arenas, finally have a chance to prove their mettle in patients. (BioWorld Today)
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.